Have pharmaceutical companies faked a sexual dysfunction?
Summary of story from Cleveland, May 18, 2011
If you’re a pharmaceutical company with a new drug to sell, it helps to have a disorder to treat. If one doesn’t exist, why not just create one – or borrow an existing disorder?
That’s an issue explored in a new documentary “Orgasm Inc.” which looks at drug firms’ efforts to develop the female version of Viagra – the proposed solution for what they label “female sexual dysfunction.”
Is female sexual dysfunction a disorder? Yes. Does 43 per cent of the female population have “some kind of sexual dysfunction,” as the drug companies posit? No.
Has that stopped Oprah, Dan Rather and even WebMD from quoting that figure? Um, no.
That number, the film says, comes from a survey done in the early 1990s, and the results have been misinterpreted.
The survey asked women about common sexual difficulties, such as a lack of desire at times.
If they answered “yes” to any of the questions, they were categorized as having “Female Sexual Dysfunction.”
The Chicago sociologist who conducted the survey, Ed Laumann, later explained that a lot of the women in the 43 per cent were “perfectly normal” and responding in a “perfectly reasonable” way to challenges and stress.
Pharmaceutical companies couldn’t resist that potential audience, however, as veteran documentary filmmaker Liz Canner says she discovered about a decade ago when she decided to take a break from making films about genocide and human-rights violations to create a movie on a lighter topic: what history and medicine say about women and pleasure.











